Mitochondrial pathology in cardiac failure

Cardiovascular Research

Volumn 49, Issue 1, 2001, Pages 17-26

  Marin Garcia, Jose ^a   Goldenthal, Michael J ^a   Moe, Gordon W ^b  

^a Molecular Cardiology Institute   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Energy metabolism; Heart failure; Mitochondria; Oxidative phosphorylation

Indexed keywords

CYTOSKELETON PROTEIN; MITOCHONDRIAL ENZYME;

APOPTOSIS; CALCIUM TRANSPORT; CELL ENERGY; HEART DILATATION; HEART FAILURE; HEART MITOCHONDRION; HEART VENTRICLE HYPERTROPHY; HUMAN; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; DNA, MITOCHONDRIAL; HEART FAILURE, CONGESTIVE; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIAL MYOPATHIES; POINT MUTATION;

EID: 0034749276     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00241-8     Document Type: Review

References (106)

1. Inherited cardiomyopathies
2. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations
3. Impaired mitochondrial function in idiopathic dilated cardiomyopathy: Biochemical and molecular analysis
4. Mitochondrial function in children with idiopathic dilated cardiomyopathy
5. Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies
6. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy
7. Mitochondrial mutation in fatal infantile cardiomyopathy
8. Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy
9. A new mtDNA mutation in the tRNA(LEU(UUR)) gene associated with maternally inherited cardiomyopathy
10. A novel mtDNA point mutation associated with mitochondrial encephalocardiomyopathy
11. Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363)
12. Maternally inherited cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(Gly) gene
13. Maternally inherited myopathy and cardiomyopathy: Association with mutation in mitochondrial DNA tRNA(Leu)
14. A novel mtDNA point mutation in maternally inherited cardiomyopathy
15. Mitochondrial DNA mutations and pathogenesis
16. Maternally inherited cardiomyopathy: An atypical presentation of the mtDNA 12S rRNA gene A1555G mutation
17. Genotype and phenotype of severe mitochondrial cardiomyopathy: A recipient of heart transplantation and the genetic control
18. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy
19. Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy
20. Cardiac involvement in mitochondrial diseases: A study of 17 patients with mitochondrial DNA defects
21. Heart disease and mitochondrial DNA mutations
22. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial point mutation (T8993G)
23. Mitochondrial biogenesis defects and neuromuscular disorders
24. Maternally inherited cardiomyopathy: A new phenotype associated with the A to G at nt 3243 in mitochondrial DNA
25. Deletions of mitochondrial DNA in Kearns-Sayre syndrome
26. An autosomal locus predisposing to deletions of mitochondrial DNA
27. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy
28. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA
29. Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy
30. Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy
31. Hypoxemia is associated with mitochondrial DNA damage and gene induction: Implications for cardiac disease
32. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy patient mitochondria
33. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR) mutation associated with maternally inherited myopathy and cardiomyopathy
34. 0 cells with mitochondria from a patient with a mitochondrial DNA point mutation in tRNA(GLY) results in respiratory chain dysfunction
35. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondria dysfunction
36. Mitochondrial toxicity of antiviral drugs
37. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of 6 cases
38. Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy
39. Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome?
40. Deficiency of the human mitochondrial transcription factor h-mtTFA in infantile mitochondrial myopathy is associated with mtDNA depletion
41. Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient
42. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
43. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
44. Molecular basis of human mitochondrial very-long-chain acyl CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood
45. Deficiency of long-chain 3-hydroxylacyl CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood
46. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency
47. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in heart/muscle isoform of the adenine nucleotide translocator
48. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
49. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial gene expression
50. The energy substrate switch during development of heart failure; gene regulatory mechanisms
51. Molecular and cellular mechanisms of myocardial failure
52. Cellular and molecular aspects of contractile dysfunction in heart failure
53. Signalling pathways for cardiac hypertrophy and failure
54. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy
55. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
56. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
57. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene
58. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
59. Identification of the Syrian hamster cardiomyopathy gene
60. An X-linked cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy gene at the Xp21
61. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene
62. Gene expression of the cardiac Na-Ca exchanger in end stage human heart failure
63. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure
64. 2+-ATPase gene
65. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca ATPase in failing and nonfailing human heart
66. Programmed myocyte death in end-stage heart failure
67. Apoptosis in the failing heart
68. Regulation of Fos and jun immediate early genes by redox or metabolic stress in cardiac myocytes
69. Superoxides relay Ras proteins oncogenic message
70. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy
71. Mitochondrial proliferation in cardiac hypertrophy
72. Coordination of nuclear and mitochondrial gene expression during the development of cardiac hypertrophy in rats
73. Biochemical and morphological study of cardiac hypertrophy. Effect of thyroxin on enzyme activities in the rat myocardium
74. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure
75. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy
76. Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy
77. Respiratory control in normal and hypertrophic hearts
78. Role of calcium ions in regulation of mammalian intramitochondrial metabolism
79. Control of mitochondrial ATP synthesis in heart
80. 2+ activation of heart mitochondrial phosphorylation: Role of the F(0)/F(1)-ATPase
81. 2+ coronary perfusion
82. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
83. Hypoxia induces apoptosis with enhanced expression of FAS antigen mRNA in cultured neonatal rat cardiomyocytes
84. Chronic hypoxia modulates the interleukin-1β stimulated inducible nitric oxide synthase pathway in cardiac myocytes
85. Rapid ventricular pacing of dogs to heart failure: Biochemical and physiological studies
86. Sarcoplasmic reticulum Ca-release channel and ATP-synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs
87. Respiratory chain defect of myocardial mitochondria in idiopathic dilated cardiomyopathy of Doberman pinscher dogs
88. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency
89. Energetics and function of the human heart with dilated or hypertrophic cardiomyopathy
90. Subcellular creatine kinase alterations. Implications in heart failure
91. Relationship between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy
92. In situ mitochondrial function in volume-overload and pressure-overload induced cardiac hypertrophy in rats
93. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy
94. Regulation of oxidative phosphorylation in the mammalian cell
95. Functional and bioenergetic consequences of postinfarction left ventricular remodelling in a new porcine model
96. Signalling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction
97. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: Role of reduced blood flow
98. Abnormalities of the skeletal muscle in hypertrophic cardiomyopathy. Spectroscopy using phosphorus-31 nuclear magnetic resonance
99. Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy
100. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance
101. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure
102. Idiopathic cardiomyopathy and skeletal muscle abnormality
103. Mitochondrial cardiomyopathy with involvement of skeletal muscle
104. Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy
105. Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome with deficiency of cytochrome c oxidase in cardiac and skeletal muscle. An enzyme histochemical-ultra-immunocytochemical-fine structural study in longterm frozen autopsy tissue
106. Deletion of mitochondrial DNA in the endomyocardial biopsy sample from a patient with Kearns-Sayre syndrome